Malignant neoplasm of right optic nerve
ICD-10 C72.31 is a billable code used to indicate a diagnosis of malignant neoplasm of right optic nerve.
C72.31 refers to a malignant neoplasm located in the right optic nerve, which is a crucial component of the central nervous system (CNS). This type of tumor can arise from glial cells, meningeal cells, or other supporting structures within the optic nerve. Symptoms may include vision loss, visual field defects, and other neurological deficits depending on the tumor's size and location. Imaging studies, particularly MRI, are essential for diagnosis, allowing for visualization of the tumor's extent and its effect on surrounding structures. Molecular markers, such as genetic mutations or specific protein expressions, may also be evaluated to guide treatment decisions and prognostication. Treatment typically involves a multidisciplinary approach, including surgical resection, radiation therapy, and possibly chemotherapy, depending on the tumor's characteristics. Neurological function assessment is critical, as the optic nerve is integral to vision, and any compromise can significantly impact a patient's quality of life.
Detailed pathology reports, imaging studies, and treatment plans.
Diagnosis and management of optic nerve tumors, treatment response evaluation.
Ensure accurate staging and grading of the tumor for appropriate coding.
Neurological assessments, imaging results, and symptom descriptions.
Evaluation of vision changes, headaches, and neurological deficits.
Document all neurological findings to support the diagnosis.
Used to evaluate the extent of the malignant neoplasm in the optic nerve.
Include imaging reports and interpretations in the medical record.
Ensure that the MRI findings correlate with clinical symptoms.
MRI is the preferred imaging modality to visualize the optic nerve and assess the extent of the tumor.
Molecular markers can provide additional information on tumor behavior and treatment options, which may be relevant for coding and documentation.
